The educational content for this online module includes:
- The Physiatrist Role in the Skilled Nursing Facility
Dr. Steven M. Gnatz, MD, MHA, and Dr. Charlotte Smith, MD, delve into this topic, providing a beneficial educational experience for the participant. A strong focus of this educational content is for the Academy to increase dynamic member engagement with all membership segments, not only to support physiatrists in anticipation of a growing workforce need, but to also cultivate a welcoming environment for our physiatrists that work in skilled nursing facilities.
Method of Study
Upon viewing the presentations, participants will need to complete a session evaluation, which includes a reflection on learning, in order to claim credit. The presentations can be viewed at one's own pace and credit can be claimed after viewing the sessions.
Accreditation Statement
The American Academy of Physical Medicine and Rehabilitation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The American Academy of Physical Medicine and Rehabilitation (AAPM&R) designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Financial Disclosures
AAPM&R requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest, which is any entity producing, marketing, re-selling or distributing health care goods or services consumed by, or used on, patients. Disclosures are made in written form prior to the start of the educational activity and any potential conflicts of interest that exist are resolved prior to the start of the activity through AAPM&R’s Conflict of Interest Disclosure and Resolution Policy Process. Individuals in a position to control content and their disclosed financial relationships are listed below.
AAPM&R Medical Education Committee:
Steven R. Flanagan, MD, Chair: Royalties from Springer Publishing; research grant from Brain Injury of America.
Anna-Christina Bevelaqua, MD: Disclosed no relevant financial relationships.
Justin M. Bishop, MD, MBA, MS: Disclosed no relevant financial relationships.
Joseph E. Burris, MD: Serves on the Speakers Bureau for, and received clinical research grants from Allergan.
John C. Cianca, MD: Ownership or partnership with Musculoskeletal Ultrasound Consultants, LLC.
Andrew B. Collins, MD: Disclosed no relevant financial relationships.
Rita G. Hamilton, DO: Disclosed no relevant financial relationships.
Mark E. Huang, MD: Nonremunerative position of influence at Cerner Corporation.
R. Sam Mayer, MD: Royalties from Demos Medical Publishing.
Andre Panagos, MD: Disclosed no relevant financial relationships.
Atul T. Patel, MD, MHSA: Speakers Bureau for Allergan, Ipsen, Merz; participates in clinical trials for Ipsen, Merz, and Revance; Guideline and AUC Committee for the AAOS, nonremunerative position of influence.
Kerrie M. Reed, MD: Disclosed no relevant financial relationships.
Sunil Sabharwal, MD: Royalities from Demos Publishing; board member, American Board of Physical Medicine and Rehabilitation.
AAPM&R CME Committee:
Karen P. Barr, MD, Chair: Disclosed no relevant financial relationships.
Rishi R. Bakshi, DO: Disclosed no relevant financial relationships.
John S. Harrell, MD: Disclosed no relevant financial relationships.
Sheryl R. Levin, MD: Disclosed no relevant financial relationships.
Didem Inanoglu, MD: Disclosed no relevant financial relationships.
Evan R. Peck, MD: Disclosed no relevant financial relationships.
Patricia T. Tan, MD: Disclosed no relevant financial relationships.
Kristin A. Wong, MD: Disclosed no relevant financial relationships.
No other planners, faculty or other individuals in control of content disclosed any relevant financial relationships.
FDA Disclosures
All faculty members for this activity have disclosed they do not intend to discuss or demonstrate any pharmaceutical or medical device for which FDA clearance has not been approved.